The estimated Net Worth of Claire Lockey is at least $1.52 Milhão dollars as of 1 November 2019. Claire Lockey owns over 10,548 units of Tricida Inc stock worth over $1,111 and over the last 6 years Claire sold TCDA stock worth over $1,515,013.
Sign up
Claire Lockey TCDA stock SEC Form 4 insiders trading
Claire has made over 10 trades of the Tricida Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently Claire exercised 10,548 units of TCDA stock worth $7,595 on 1 November 2019.
The largest trade Claire's ever made was exercising 52,925 units of Tricida Inc stock on 28 March 2019 worth over $92,090. On average, Claire trades about 14,547 units every 26 days since 2018. As of 1 November 2019 Claire still owns at least 10,100 units of Tricida Inc stock.
You can see the complete history of Claire Lockey stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Claire Lockey's mailing address?
Claire's mailing address filed with the SEC is 7000 Shoreline Ct #201, South San Francisco, CA 94080, USA.
Insiders trading at Tricida Inc
Over the last 6 years, insiders at Tricida Inc have traded over $198,373,537 worth of Tricida Inc stock and bought 7,174,449 units worth $105,536,837 . The most active insiders traders include David P Bonita, Advisors Llc Orbi Med Capit..., eHealthcare Capital Partners.... On average, Tricida Inc executives and independent directors trade stock every 8 days with the average trade being worth of $22,553. The most recent stock trade was executed by Robert J Alpern on 23 November 2022, trading 131,879 units of TCDA stock currently worth $27,695.
What does Tricida Inc's logo look like?
Complete history of Claire Lockey stock trades at Tricida Inc
Tricida Inc executives and stock owners
Tricida Inc executives and other stock owners filed with the SEC include:
-
Gerrit Klaerner,
President, Chief Executive Officer, Director -
Dawn Parsell,
Executive Vice President - Clinical Development -
Geoffrey Parker,
Chief Financial Officer, Executive Vice President -
Edward Hejlek,
Senior Vice President -
Dr. Gerrit Klaerner Ph.D.,
Founder, Pres, CEO & Exec. Director -
Dr. Dawn Parsell Ph.D.,
Exec. VP of Clinical Devel. -
Geoffrey M. Parker,
COO, CFO & Exec. VP -
Robert L. McKague J.D.,
Exec. VP, Company Sec., Gen. Counsel & Chief Compliance Officer -
Dr. Wilhelm Stahl,
Exec. VP & CTO -
Klaus Veitinger,
Independent Chairman of the Board -
David Bonita,
Independent Director -
Kathryn Falberg,
Independent Director -
David Hirsch,
Independent Director -
Sandra Coufal,
Independent Director -
Robert Alpern,
Independent Director -
Marc Cobo,
Senior Vice President - Finance, Chief Accounting Officer -
Robert McKague,
Executive Vice President, General Counsel, Secretary -
Edward J. Hejlek Esq., J.D.,
Exec. VP of Intellectual Property -
Jackie Cossmon,
VP of Investor Relations & Communications -
Annie Yoshiyama,
VP of Fin. & Chief Accounting Officer -
Claire Lockey,
Chief Dev. Officer and Sr. VP -
Brian M.Sibling Capital Fun...,
-
Brian M.Sibling Capital Fun...,
-
Brian M.Sibling Capital Ven...,
-
Beek Jeroen B Van,
Chief Comm Officer and Sr VP -
Steffen Pietzke,
VP Fin & Chief Acct Officer -
Capital Partners Ii, Llc Lo...,
-
Advisors Llc Orbi Med Capit...,
-
Harbor Master Investors (Ca...,
10% owner -
Wilhelm Stahl,
EVP, Chief Tech Officer -
Brian M.Sibling Capital Ven...,
-
Susannah Cantrell,
EVP, Chief Comm. Officer -
Brian M.Sibling Capital Fun...,
-
Brian M.Sibling Capital Fun...,
-
Annie Yoshiyama,
Senior VP, Finance and CAO -
Healthcare Capital Partners...,